Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Pharmaco-genomics Pharmaco-metabolomics Pharmaco-transcriptomics Pharmaco-proteomics Search

Displaying entries 56951 - 56975 of 102031 in total

Drug	Drug Groups	Gene	Gene ID	Change	Interaction	Chromosome	References
							Clear
Pentaerythritol tetranitrate	Approved Withdrawn	FTH1	2495	upregulated	Pentaerythritol Tetranitrate results in increased expression of FTH1 mRNA	11q12.3	A23586
Pentaerythritol tetranitrate	Approved Withdrawn	HMOX1	3162	upregulated	Pentaerythritol Tetranitrate results in increased expression of HMOX1 mRNA	22q12.3	A23586
Pentamidine	Approved Investigational	ASNS	440	upregulated	Pentamidine results in increased expression of ASNS mRNA	7q21.3	A20438
Pentamidine	Approved Investigational	FABP1	2168	downregulated	Pentamidine results in decreased expression of FABP1 mRNA	2p11.2	A20438
Pentamidine	Approved Investigational	FNDC4	64838	upregulated	Pentamidine results in increased expression of FNDC4 mRNA	2p23.3	A20438
Pentamidine	Approved Investigational	HPN	3249	upregulated	Pentamidine results in increased expression of HPN mRNA	19q13.11	A20438
Pentamidine	Approved Investigational	IFNGR1	3459	upregulated	Pentamidine results in increased expression of IFNGR1 mRNA	6q23.3	A20682
Pentamidine	Approved Investigational	INHBE	83729	upregulated	Pentamidine results in increased expression of INHBE mRNA	12q13.3	A20438
Pentamidine	Approved Investigational	LSS	4047	downregulated	Pentamidine results in decreased expression of LSS mRNA	21q22.3	A20438
Pentamidine	Approved Investigational	NR0B2	8431	upregulated	Pentamidine results in increased expression of NR0B2 mRNA	1p36.11	A20438
Pentamidine	Approved Investigational	NUPR1	26471	upregulated	Pentamidine results in increased expression of NUPR1 mRNA	16p11.2	A20438
Pentamidine	Approved Investigational	SERPINA3	12	upregulated	Pentamidine results in increased expression of SERPINA3 mRNA	14q32.13	A20438
Pentamidine	Approved Investigational	SLC2A3	6515	downregulated	Pentamidine results in decreased expression of SLC2A3 mRNA	12p13.31	A20438
Pentamidine	Approved Investigational	WIPI1	55062	upregulated	Pentamidine results in increased expression of WIPI1 mRNA	17q24.2	A20438
Pentanal	Experimental	A1BG	1	upregulated	pentanal results in increased expression of A1BG mRNA	19q13.43	A23587
Pentanal	Experimental	ABAT	18	upregulated	pentanal results in increased expression of ABAT mRNA	16p13.2	A23587
Pentanal	Experimental	ABCG4	64137	upregulated	pentanal results in increased expression of ABCG4 mRNA	11q23.3	A23587
Pentanal	Experimental	ABLIM3	22885	upregulated	pentanal results in increased expression of ABLIM3 mRNA	5q32	A23587
Pentanal	Experimental	ACE2	59272	upregulated	pentanal results in increased expression of ACE2 mRNA	Xp22.2	A23587
Pentanal	Experimental	ACMSD	130013	downregulated	pentanal results in decreased expression of ACMSD mRNA	2q21.3	A23587
Pentanal	Experimental	ACP1	52	downregulated	pentanal results in decreased expression of ACP1 mRNA	2p25.3	A23587
Pentanal	Experimental	ACVR2B-AS1	100128640	downregulated	pentanal results in decreased expression of ACVR2B-AS1 mRNA	3p22.2	A23587
Pentanal	Experimental	ADAM11	4185	upregulated	pentanal results in increased expression of ADAM11 mRNA	17q21.31	A23587
Pentanal	Experimental	ADAM19	8728	upregulated	pentanal results in increased expression of ADAM19 mRNA	5q33.3	A23587
Pentanal	Experimental	ADAMTS10	81794	downregulated	pentanal results in decreased expression of ADAMTS10 mRNA	19p13.2	A23587

Displaying entries 56951 - 56975 of 102031 in total

Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Advanced Filter

Filter by Group

Filter by Market Availability